Wolverine Trading
NTLA icon

Wolverine Trading’s Intellia Therapeutics NTLA Stock Holding History

Wolverine Trading’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.12M Buy
+66,400
New +$818K ﹤0.01% 2772
2025
Q2 		– Sell
-23,700
Closed -$191K – 5313
2025
Q1 		$191K Sell
23,700
-2,900
-11% -$29.3K ﹤0.01% 3978
2024
Q4 		$304K Sell
26,600
-2,600
-9% -$40.6K ﹤0.01% 3996
2024
Q3 		$613K Buy
29,200
+6,300
+28% +$145K ﹤0.01% 2859
2024
Q2 		$513K Buy
22,900
+1,700
+8% +$40.5K ﹤0.01% 2828
2024
Q1 		$583K Buy
21,200
+600
+3% +$16.7K ﹤0.01% 2689
2023
Q4 		$628K Sell
20,600
-3,400
-14% -$97.7K ﹤0.01% 2719
2023
Q3 		$759K Sell
24,000
-2,500
-9% -$97K ﹤0.01% 2363
2023
Q2 		$1.08M Buy
26,500
+2,200
+9% +$89.2K ﹤0.01% 1947
2023
Q1 		$875K Sell
24,300
-14,600
-38% -$573K ﹤0.01% 2014
2022
Q4 		$1.36M Sell
38,900
-3,400
-8% -$162K ﹤0.01% 1630
2022
Q3 		$2.34M Buy
42,300
+2,100
+5% +$130K ﹤0.01% 1301
2022
Q2 		$2.11M Buy
40,200
+31,200
+347% +$1.58M ﹤0.01% 1343
2022
Q1 		$650K Buy
9,000
+2,100
+30% +$178K ﹤0.01% 2930
2021
Q4 		$837K Sell
6,900
-9,800
-59% -$1.23M ﹤0.01% 2834
2021
Q3 		$2.3M Sell
16,700
-4,300
-20% -$651K ﹤0.01% 2008
2021
Q2 		$3.18M Buy
21,000
+5,500
+35% +$428K ﹤0.01% 1533
2021
Q1 		$1.12M Buy
+15,500
New +$1.04M ﹤0.01% 2606

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's NTLA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Intellia Therapeutics (NTLA) in Q3 2025: 21,438 shares worth $363K. The stake represents ﹤0.01% of the portfolio and ranks #4105 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in NTLA as recently as Q4 2024.

Wolverine Trading first reported a position in NTLA in Q1 2021 and has held it in 16 quarters since. The position peaked at $901K in Q3 2021. 282 funds tracked by Wall St. Rank hold NTLA as of Q3 2025.

  • Wolverine Trading held 21,438 shares of Intellia Therapeutics worth $363K as of Q3 2025.
  • Intellia Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Intellia Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4105 holding.
  • Wolverine Trading first reported a position in Intellia Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Wolverine Trading's Intellia Therapeutics position peaked at $901K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.